Circular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma

Abstract Circular RNAs (circRNAs) represent potential biomarkers because of their highly stable structure and robust expression pattern in clinical samples. The aim of this study was to evaluate the expression of a recently identified circRNA, hsa_circ_0005986; determine its clinical significance; a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gyeonghwa Kim, Ja Ryung Han, Soo Young Park, Won Young Tak, Young-Oh Kweon, Yu Rim Lee, Young Seok Han, Jung Gil Park, Min Kyu Kang, Hye Won Lee, Won Kee Lee, Deokhoon Kim, Se Young Jang, Keun Hur
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1e0193e6150d4d6f95afc5634489bdfb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1e0193e6150d4d6f95afc5634489bdfb
record_format dspace
spelling oai:doaj.org-article:1e0193e6150d4d6f95afc5634489bdfb2021-12-02T16:17:21ZCircular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma10.1038/s41598-021-94074-y2045-2322https://doaj.org/article/1e0193e6150d4d6f95afc5634489bdfb2021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-94074-yhttps://doaj.org/toc/2045-2322Abstract Circular RNAs (circRNAs) represent potential biomarkers because of their highly stable structure and robust expression pattern in clinical samples. The aim of this study was to evaluate the expression of a recently identified circRNA, hsa_circ_0005986; determine its clinical significance; and evaluate its potential as a biomarker of hepatocellular carcinoma (HCC). We evaluated hsa_circ_0005986 expression in 123 HCC tissue samples, its clinical significance, and its association with patients’ clinicopathological characteristics and survival. Hsa_circ_0005986 expression was downregulated in HCC tissues. Low hsa_circ_0005986 expression was more common in tumors larger than 5 cm [odds ratio (OR), 3.19; 95% confidence interval (CI), 1.51–6.76; p = 0.002], advanced TNM stage (III/IV; OR, 2.39; 95% CI, 1.16–4.95; p = 0.018), and higher BCLC stage (B/C; OR, 2.71; 95% CI, 1.30–5.65; p = 0.007). High hsa_circ_0005986 expression was associated with improved survival and was an independent prognostic factor for overall [hazard ratio (HR), 0.572; 95% CI, 0.339–0.966; p = 0.037] and progression-free (HR, 0.573; 95% CI, 0.362–0.906; p = 0.017) survival. Moreover, the circRNA–miRNA–mRNA network was constructed using RNA-seq/miRNA-seq data and clinical information from TCGA-LIHC dataset. Our findings indicate a promising role for hsa_circ_0005986 as a prognostic biomarker in patients with HCC.Gyeonghwa KimJa Ryung HanSoo Young ParkWon Young TakYoung-Oh KweonYu Rim LeeYoung Seok HanJung Gil ParkMin Kyu KangHye Won LeeWon Kee LeeDeokhoon KimSe Young JangKeun HurNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Gyeonghwa Kim
Ja Ryung Han
Soo Young Park
Won Young Tak
Young-Oh Kweon
Yu Rim Lee
Young Seok Han
Jung Gil Park
Min Kyu Kang
Hye Won Lee
Won Kee Lee
Deokhoon Kim
Se Young Jang
Keun Hur
Circular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma
description Abstract Circular RNAs (circRNAs) represent potential biomarkers because of their highly stable structure and robust expression pattern in clinical samples. The aim of this study was to evaluate the expression of a recently identified circRNA, hsa_circ_0005986; determine its clinical significance; and evaluate its potential as a biomarker of hepatocellular carcinoma (HCC). We evaluated hsa_circ_0005986 expression in 123 HCC tissue samples, its clinical significance, and its association with patients’ clinicopathological characteristics and survival. Hsa_circ_0005986 expression was downregulated in HCC tissues. Low hsa_circ_0005986 expression was more common in tumors larger than 5 cm [odds ratio (OR), 3.19; 95% confidence interval (CI), 1.51–6.76; p = 0.002], advanced TNM stage (III/IV; OR, 2.39; 95% CI, 1.16–4.95; p = 0.018), and higher BCLC stage (B/C; OR, 2.71; 95% CI, 1.30–5.65; p = 0.007). High hsa_circ_0005986 expression was associated with improved survival and was an independent prognostic factor for overall [hazard ratio (HR), 0.572; 95% CI, 0.339–0.966; p = 0.037] and progression-free (HR, 0.573; 95% CI, 0.362–0.906; p = 0.017) survival. Moreover, the circRNA–miRNA–mRNA network was constructed using RNA-seq/miRNA-seq data and clinical information from TCGA-LIHC dataset. Our findings indicate a promising role for hsa_circ_0005986 as a prognostic biomarker in patients with HCC.
format article
author Gyeonghwa Kim
Ja Ryung Han
Soo Young Park
Won Young Tak
Young-Oh Kweon
Yu Rim Lee
Young Seok Han
Jung Gil Park
Min Kyu Kang
Hye Won Lee
Won Kee Lee
Deokhoon Kim
Se Young Jang
Keun Hur
author_facet Gyeonghwa Kim
Ja Ryung Han
Soo Young Park
Won Young Tak
Young-Oh Kweon
Yu Rim Lee
Young Seok Han
Jung Gil Park
Min Kyu Kang
Hye Won Lee
Won Kee Lee
Deokhoon Kim
Se Young Jang
Keun Hur
author_sort Gyeonghwa Kim
title Circular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma
title_short Circular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma
title_full Circular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma
title_fullStr Circular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma
title_full_unstemmed Circular noncoding RNA hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma
title_sort circular noncoding rna hsa_circ_0005986 as a prognostic biomarker for hepatocellular carcinoma
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/1e0193e6150d4d6f95afc5634489bdfb
work_keys_str_mv AT gyeonghwakim circularnoncodingrnahsacirc0005986asaprognosticbiomarkerforhepatocellularcarcinoma
AT jaryunghan circularnoncodingrnahsacirc0005986asaprognosticbiomarkerforhepatocellularcarcinoma
AT sooyoungpark circularnoncodingrnahsacirc0005986asaprognosticbiomarkerforhepatocellularcarcinoma
AT wonyoungtak circularnoncodingrnahsacirc0005986asaprognosticbiomarkerforhepatocellularcarcinoma
AT youngohkweon circularnoncodingrnahsacirc0005986asaprognosticbiomarkerforhepatocellularcarcinoma
AT yurimlee circularnoncodingrnahsacirc0005986asaprognosticbiomarkerforhepatocellularcarcinoma
AT youngseokhan circularnoncodingrnahsacirc0005986asaprognosticbiomarkerforhepatocellularcarcinoma
AT junggilpark circularnoncodingrnahsacirc0005986asaprognosticbiomarkerforhepatocellularcarcinoma
AT minkyukang circularnoncodingrnahsacirc0005986asaprognosticbiomarkerforhepatocellularcarcinoma
AT hyewonlee circularnoncodingrnahsacirc0005986asaprognosticbiomarkerforhepatocellularcarcinoma
AT wonkeelee circularnoncodingrnahsacirc0005986asaprognosticbiomarkerforhepatocellularcarcinoma
AT deokhoonkim circularnoncodingrnahsacirc0005986asaprognosticbiomarkerforhepatocellularcarcinoma
AT seyoungjang circularnoncodingrnahsacirc0005986asaprognosticbiomarkerforhepatocellularcarcinoma
AT keunhur circularnoncodingrnahsacirc0005986asaprognosticbiomarkerforhepatocellularcarcinoma
_version_ 1718384218075037696